SEQENS
Created in 2003
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
381 573 39,744Entity types
Location
21 Chem. de la Sauvegarde, 69130 Écully, France
Écully
France
Employees
Scale: 1001-5000
Estimated: 1,279
SIREN
444465736Engaged corporates
39
9 30Added in Motherbase
3 years, 7 months ago
Large company Value proposition
Our science for your future
SEQENS is a worldwide leader in pharmaceutical solutions and specialty ingredients.
The group generates a revenue of 1.1 MM€ and operates 16 manufacturing plants and 9 R&D centers in Europe, North America and Asia. 3,300 employees contribute to the success of SEQENS, among which 350 scientists, engineers and experts who develop tailor-made solutions for our customers.
SEQENS is an integrated player offering a broad portfolio of active ingredients, pharmaceutical intermediates and specialty ingredients. We develop and industrialize the most demanding molecules, and rely on our ability to innovate, develop and implement the best available technologies.
Pharmaceutical Synthesis, Specialty Ingredients, Cosmetics, Custom Specialties, R&D, CDMO, CRDO, Generics, Innovative Pharmaceuticals, and Personnal CareOriginal language
Our science for your future
Seqens est un leader mondial de la synthèse pharmaceutique et des ingrédients de spécialité.
Le groupe génère un chiffre d'affaires de 1.1 milliard d'€ et exploite 16 sites de production ainsi que 9 centres de R&D en Europe, en Amérique du Nord et en Asie. 3 300 collaborateurs contribuent au succès de Seqens, parmi lesquels plus de 350 scientifiques, ingénieurs et experts qui développent des solutions sur mesure pour nos clients.
Seqens est un acteur intégré qui offre un large portefeuille de principes actifs, d'intermédiaires pharmaceutiques et d'ingrédients de spécialité. Nous développons et industrialisons les molécules les plus exigeantes, en prenant appui sur notre capacité à innover, à développer et à mettre en œuvre les meilleures technologies disponibles.
Pharmaceutical Solutions, Personal Care & Specialty Ingredients - SEQENS
SEQENS is an integrated global leader in Health, Personal Care and Specialty Ingredients with 16 production sites and 9 R&D centres across the world,
https://www.seqens.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Groupe TF1 Media, Broadcast Media Production and Distribution | Groupe TF1 Media, Broadcast Media Production and Distribution | Other 11 Sep 2024 | | |
 Région Ile de France National and local authorities, Government Administration | Région Ile de France National and local authorities, Government Administration | Other 5 Jul 2024 | | |
 ESTER Technopole Think Tanks | ESTER Technopole Think Tanks | Other 31 Dec 2023 | | |
 France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | Other 12 Dec 2023 | | |
 Moderna Pharmaceutical, Biotechnology, Biotechnology Research | Moderna Pharmaceutical, Biotechnology, Biotechnology Research | Other 30 Oct 2023 | | |
 CEA Research | CEA Research | Other 25 Jul 2024 | | |
 Linkcity Real Estate | Linkcity Real Estate | Other 24 Oct 2023 | | |
 Genopole Biotechnology, Biotechnology Research | Genopole Biotechnology, Biotechnology Research | Other 22 Sep 2023 | | |
 CleanTech Vallée Startup accelerator & VC, Environmental Services | CleanTech Vallée Startup accelerator & VC, Environmental Services | Other 14 Sep 2023 | | |
 Axel'One Research Services | Axel'One Research Services | Other 20 Sep 2023 | | |